Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).

ABSTRACT:

SUBMITTER: Halbherr S 

PROVIDER: S-EPMC12101738 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature